Home > News > FDA fast-tracks anti-HIV and herpes gel
January 11th, 2006
FDA fast-tracks anti-HIV and herpes gel
Abstract:
Australian pharmaceutical company StarPharma announced Tuesday that the Food and Drug Administration has granted fast-track status to VivaGel, an investigational microbicidal gel that women would apply vaginally in the hours before intercourse to prevent transmission of HIV and genital herpes.
(ED.'s note: "A vaginal gel that incorporates nanotechnology" - someday, we hope, writers will learn that "nanotechnology" is not a thing; in the context of this article, it is simply materials science. A more accurate sentence would be "A vaginal gel that incorporates nanoscale materials, in specific, dendrimers ...")
Source:
upi.com
Related Links |
Related News Press |
Possible Futures
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
With VECSELs towards the quantum internet Fraunhofer: IAF achieves record output power with VECSEL for quantum frequency converters April 5th, 2024
Nanomedicine
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Good as gold - improving infectious disease testing with gold nanoparticles April 5th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
Materials/Metamaterials/Magnetoresistance
Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024
Focused ion beam technology: A single tool for a wide range of applications January 12th, 2024
Announcements
NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||